Marina Kem
Harvard University(US)Massachusetts General Hospital(US)
Publications by Year
Research Areas
Lung Cancer Research Studies, Peptidase Inhibition and Analysis, Cancer therapeutics and mechanisms, Cancer Immunotherapy and Biomarkers, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment(2022)377 cited
- → Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer(2019)235 cited
- → Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts(2018)215 cited
- → Clinicopathologic Characteristics of BRG1-Deficient NSCLC(2020)145 cited
- → Accuracy and Reproducibility of Intraoperative Assessment on Tumor Spread Through Air Spaces in Stage 1 Lung Adenocarcinomas(2020)70 cited
- → Immune checkpoint inhibitor-associated celiac disease(2020)66 cited
- → Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition(2020)65 cited
- → Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival(2017)62 cited
- → Nuclear IL‐33/SMAD signaling axis promotes cancer development in chronic inflammation(2021)61 cited
- → Differential expression of PD-L1 and IDO1 in association with the immune microenvironment in resected lung adenocarcinomas(2018)45 cited